Hypereosinophilic syndrome: A multicenter, retrospective analysis of clinical characteristics and response to therapy
National Institute of Allergy and Infectious Diseases · National Institutes of Health · +14 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
620
total citations
- FWCI
- 16.70
- Percentile
- 100%
- References
- 19
Citations per year
Authors
20- PUPrincess U. Ogbogu
National Institute of Allergy and Infectious Diseases, National Institutes of Health
- BSBruce S. Bochner
Johns Hopkins Medicine, Johns Hopkins University
- JHJoseph H. Butterfield
Mayo Clinic
- GJGerald J. Gleich
University of Utah
- JHJohannes Huss‐Marp
Technical University of Munich, Helmholtz Zentrum München
Topics & keywords
Topics
Keywords
- Medicine
- Mepolizumab
- Hypereosinophilic syndrome
- Internal medicine
- Prednisone
- PDGFRA
- Eosinophilia
- Population
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.
Funding
- NSNational Science Foundation
- GGlaxoSmithKline
- DODivision of Intramural Research, National Institute of Allergy and Infectious Diseases
- JHJohns Hopkins University
- SNSchweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- FDFonds De La Recherche Scientifique - FNRS
- NINational Institutes of HealthAwards: AI41472, AI72265
- NINational Institute of Allergy and Infectious DiseasesAward: AI72265
- NDNHLBI Division of Intramural Research